Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

[Study of the complement system. General principles and perspectives].

Julen N, Dauchel H, Lemercier C, Daveau M, Fontaine M, Sauger F, Maitrot B, Ripoche J.

Ann Biol Clin (Paris). 1990;48(6):349-60. Review. French.

PMID:
2221493
2.

A novel ELISA for the evaluation of the classical pathway of complement.

Zwirner J, Wittig A, Kremmer E, Götze O.

J Immunol Methods. 1998 Feb 1;211(1-2):183-90.

PMID:
9617842
3.

Methods for assessing complement activation in the clinical immunology laboratory.

Porcel JM, Peakman M, Senaldi G, Vergani D.

J Immunol Methods. 1993 Jan 4;157(1-2):1-9. Review.

PMID:
8423350
4.

Complement activation during CAPD.

Young GA, Kendall S, Brownjohn AM.

Nephrol Dial Transplant. 1993;8(12):1372-5.

PMID:
8159307
5.

A knowledge-based system for automatic interpretation of an analytical profile of complement factors.

Wiener F, Groth T, Nilsson U.

J Clin Lab Anal. 1989;3(5):287-95.

PMID:
2809879
6.

Complement activation in patients with systemic lupus erythematosus without nephritis.

Mollnes TE, Haga HJ, Brun JG, Nielsen EW, Sjöholm A, Sturfeldt G, Mårtensson U, Bergh K, Rekvig OP.

Rheumatology (Oxford). 1999 Oct;38(10):933-40.

PMID:
10534542
7.

New advances in measurement of complement activation: lessons of systemic lupus erythematosus.

Liu CC, Manzi S, Danchenko N, Ahearn JM.

Curr Rheumatol Rep. 2004 Oct;6(5):375-81. Review.

PMID:
15355750
8.

Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.

Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.

Cancer Res. 1993 Feb 1;53(3):592-9.

9.

Complement: activation, consequences, and control.

James K.

Am J Med Technol. 1982 Sep;48(9):735-42. Review.

PMID:
6215861
10.
11.

Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.

Wouters D, Wiessenberg HD, Hart M, Bruins P, Voskuyl A, Daha MR, Hack CE.

J Immunol Methods. 2005 Mar;298(1-2):35-45.

PMID:
15847795
12.

The effect of aging on complement activity (CH50) and complement protein levels.

Nagaki K, Hiramatsu S, Inai S, Sasaki A.

J Clin Lab Immunol. 1980 Jan;3(1):45-50.

PMID:
7381926
13.

Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.

Gyongyossy-Issa MI, McLeod E, Devine DV.

J Lab Clin Med. 1994 Jun;123(6):859-68.

PMID:
8201264
14.

Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.

Boeckler P, Meyer A, Uring-Lambert B, Goetz J, Cribier B, Hauptmann G, Lipsker D.

Clin Immunol. 2006 Nov;121(2):198-202.

PMID:
16987709
15.

Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers.

Dauchel H, Joly P, Delpech A, Thomine E, Sauger F, Le Loet X, Lauret P, Tron F, Fontaine M, Ripoche J.

Clin Exp Immunol. 1993 May;92(2):274-83.

16.

Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.

Miyano A, Nakayama M, Fujita T, Kitajima H, Imai S, Shimizu A.

Diagn Clin Immunol. 1987;5(2):86-90.

PMID:
3497734
17.
18.
19.
20.

Complement activation during storage of whole blood, red cells, plasma, and buffy coat.

Hyllner M, Arnestad JP, Bengtson JP, Rydberg L, Bengtsson A.

Transfusion. 1997 Mar;37(3):264-8.

PMID:
9122898

Supplemental Content

Support Center